Physician profile
Roger Scott Cooley
NPI 1568646818
$1,383.92
in general payments reported to CMS, 2019-2025
11 companies · $631 in 2025
The $631 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.66 · 2020: $113 · 2021: $28.87 · 2022: $20.45 · 2023: $137 · 2024: $371 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,139.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $530.89 | 2023-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $318.27 | 2019-2024 | Xifaxan, Trulance |
| Ardelyx, INC. | $259.37 | 2023-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $85.11 | 2025 | Dupixent |
| Romark Laboratories, Lc | $47.32 | 2020 | |
| Phathom Pharmaceuticals, INC. | $40.67 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $27.03 | 2025 | Tremfya |
| Ironwood Pharmaceuticals, INC | $23.14 | 2023 | Linzess |
| Merck Sharp & Dohme LLC | $20.45 | 2022 | |
| Redhill Biopharma INC. | $16.68 | 2020 | |
| Braintree Laboratories, INC. | $14.99 | 2024 | Sutab, Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.